FAST & Fellows Round Up
Read the latest in FAST and Fellows news:
- Encellin’s (FAST Spring 2017) insulin-releasing implant for Type-1 Diabetes featured on NPR Read More
- LogicInk (FAST Spring 2017) announced their first product, LogicInk UV, an electronics-free temporary wearable powered by programmable ink Read More
- Eidos Therapeutics (FAST Spring 2016) initiates Phase 1 trial of AG10, an orally bioavailable, small molecule stabilizer of transthyretin (TTR) Read More
- EpiBiome (FAST Spring 2015) featured in The Economist on understanding how the microbiome is helping medicine Read More
To learn more about the CLSA Fellows program – the significantly discounted membership for life science startups – click here.
The FAST (Fellows All-Star Team) Accelerator provides select entrepreneurs with intensive team review and coaching to perfect their business model, product development plans, and to build a compelling commercialization strategy. Experienced entrepreneurs, product and business experts (which may include clinical development, regulatory, reimbursement, and business development specialists) will advise selected Fellows during a ten-to-twelve week program, culminating in a Final FAST Showcase to a broad audience that includes potential investors and partners.